PACBVSSFWL• 6 Months (Normalized)
PACB vs SFWL (Pacific Biosciences of California Inc. vs Shengfeng Development Limited)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.87
+112.59%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
SFWL Performance $8.82
+764.71%
Shengfeng Development Limited
Normalized Baseline0.00%
Alpha Spread Margin SFWL LEADS
-652.12 pts
SFWL outperforming by 652.12 percentage points
PACBSFWL
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB SFWL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | PACB Price | PACB Gain (%) | SFWL Price | SFWL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.87 | +112.59% | $8.82 | +764.71% | -652.12% |
| Oct 02, 2026 | $2.54 | +88.15% | $8.35 | +718.63% | -630.48% |
| Oct 01, 2026 | $2.51 | +85.93% | $8.81 | +763.73% | -677.80% |
| Sep 30, 2026 | $2.37 | +75.56% | $8.90 | +772.55% | -696.99% |
| Sep 29, 2026 | $1.83 | +35.56% | $8.90 | +772.55% | -736.99% |
| Sep 28, 2026 | $1.71 | +26.67% | $8.90 | +772.55% | -745.88% |
| Sep 24, 2026 | $1.46 | +7.78% | $- | - | |
| Sep 23, 2026 | $1.41 | +4.44% | $8.48 | +731.37% | -726.93% |
| Sep 22, 2026 | $- | $8.83 | +765.20% | - | |
| Sep 21, 2026 | $1.36 | +0.74% | $8.48 | +731.37% | -730.63% |
| Sep 18, 2026 | $1.37 | +1.48% | $8.28 | +711.67% | -710.19% |
| Sep 17, 2026 | $1.38 | +2.22% | $9.00 | +781.86% | -779.64% |
| Sep 16, 2026 | $1.34 | -0.74% | $9.00 | +782.35% | -783.09% |
| Sep 15, 2026 | $1.34 | -0.74% | $9.20 | +801.96% | -802.70% |
| Sep 14, 2026 | $1.35 | +0.00% | $8.19 | +702.94% | -702.94% |
Page 1 of 9